Alexis Guédon: Cardiovascular Risk Profiles and Outcomes in Patients With Giant Cell Arteritis
Alexis Guédon, Junior Deputy Editor at the European Journal of Preventive Cardiology, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
“I’m very happy to announce that our latest research article has just been published online ahead of print in the European Journal of Preventive Cardiology!
In this large nationwide cohort study, we examined the cardiovascular risk profiles and outcomes of patients with Giant Cell Arteritis (GCA) compared to matched control populations. Our findings highlight significantly increased risks of MACE, aortic, peripheral arterial, and visceral artery events in GCA patients – underscoring the critical importance of cardiovascular risk management and inflammation control in this population.
Key insights include:
- GCA is associated with elevated risk of major vascular complications.
- Disease activity is associated with major adverse cardiovascular events, highlighting the role of systemic inflammation.
Many thanks to all co-authors and collaborators who made this work possible!
Article: Cardiovascular risk among Giant cell arteritis patients
Authors: Alexis F Guedon, Olivier Espitia, Maxime Beydon, Etienne Ghrenassia, Tristan Mirault, Emmanuel Messas, Florence Tubach, Raphaèle Seror, Franck Boccara, Ariel Cohen, Ruth Frikke-Schmidt, Børge Grønne Nordestgaard, Azeddine Dellal, Olivier Fain, Arsène Mekinian, Fabrice Carrat
Read the Full Article on European Journal of Preventive Cardiology”
Stay updated on all scientific advances with Hemostasis Today.
-
May 6, 2026, 11:30Paula Caporal: Consensus on the Diagnosis and Management of Pediatric Stroke in Argentina
-
May 6, 2026, 11:14Li Khim Kwah: Proud for the Development of The New Singapore Stroke Rehabilitation Guideline
-
May 6, 2026, 10:55Hugo Antonio Romo Rubio: A New Paradigm in Treatment for Hemophilia A from FRONTIERS2 Phase 3 Study
-
May 6, 2026, 10:40Ifeanyichukwu Ifechidere: Why INR Can Be Dangerously Misleading
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Connecting with so Many Families and Advocates at HFA 2026
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?
-
May 6, 2026, 02:23Khaled Musallam: When the Worlds of Thalassemia and Hemophilia Converge
-
May 6, 2026, 02:12Caitlin Raymond: How STOP-BABESIOSIS Just Rewrote 40 Years of Practice